ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 89 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $165,000 | -38.4% | 33,530 | -33.9% | 0.00% | -50.0% |
| Q2 2021 | $268,000 | -81.4% | 50,703 | -83.1% | 0.00% | -81.8% |
| Q1 2021 | $1,441,000 | +50.1% | 300,246 | +35.4% | 0.01% | +37.5% |
| Q4 2020 | $960,000 | +32.4% | 221,790 | +26.0% | 0.01% | 0.0% |
| Q3 2020 | $725,000 | +123.8% | 175,990 | +38.9% | 0.01% | +100.0% |
| Q2 2020 | $324,000 | -31.8% | 126,703 | -22.9% | 0.00% | -33.3% |
| Q1 2020 | $475,000 | -16.4% | 164,356 | +9.6% | 0.01% | 0.0% |
| Q4 2019 | $568,000 | +41.3% | 149,979 | +90.8% | 0.01% | +20.0% |
| Q3 2019 | $402,000 | +18.9% | 78,600 | +307.3% | 0.01% | -16.7% |
| Q1 2015 | $338,000 | – | 19,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |